Clinical trials referenced in this document:
Documents that mention this clinical trial
Plasma heat shock protein response to euglycemia in type 2 diabetes
Angiopoietin-1: an early biomarker of diabetic nephropathy?
Amyloid-related protein changes associated with dementia differ according to severity of hypoglycemia
Renin-Angiotensin System Overactivation in Type 2 Diabetes: A Risk for SARS-CoV-2 Infection?
Received: 1 October 2021
Accepted: 4 October 2021
First Online: 13 October 2021
: The trial was approved by the North West-Greater Manchester East Research Ethics Committee (REC number: 16/NW/0518), registered at ExternalRef removed (NCT03102801) on 06/04/2017 and conducted according to the Declaration of Helsinki. All participants provided written informed consent.
: All authors gave their consent for publication.
: No authors have any conflict of interest or competing interests to declare.